Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Clinical trials vs real-world results What the clinical trials show The landmark SURMOUNT-5 trial published in 2025 compared these medications directly at standard maximum doses: 1 Mounjaro (tirzepatide 15 mg) produced 20.2% average weight loss Wegovy (semaglutide 2.4 mg) produced 13.7% average weight loss The 6.5 percentage point difference was statistically significant This trial used the maximum approved doses at the time (Mounjaro 15 mg, Wegovy 2.4 mg) and lasted 72 weeks
Compounding pharmacies can mix, alter, or combine active ingredients to create a medication tailored for a patients specific needs
Those with a history of gastroparesis, for example, should be especially cautious as Retatrutide slows gastric emptying further
Due to their amphiphilic composition, liposomes can transport both water-soluble (hydrophilic) and fat-soluble (hydrophobic) substances, making them extremely versatile and efficient in delivering active ingredients directly to the cells or tissues that need them most
